Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar

Rhea-AI Summary

Reliq Health Technologies Inc. (OTC:RQHTF) announced a webinar scheduled for November 30, 2021, to discuss its Q1 Fiscal Year 2022 financial results and provide a corporate update. CEO Dr. Lisa Crossley stated the company is on track to achieve a $2 million/month revenue run rate by year-end 2021, with gross margins of 75% and EBITDA margins of 45%. The company anticipates significant quarter-over-quarter growth through 2022 as Medicare and Medicaid expand virtual care reimbursement.

Positive

• Projected revenue run rate of $2 million/month by end of 2021.
• Gross margins of 75% and EBITDA margins of 45%.
• Anticipated significant quarter-over-quarter growth through 2022.

Negative

• None.

HAMILTON, Ontario, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global medtech company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, wishes to inform shareholders that it will be hosting a webinar on November 30, 2021 at 6:00am PST / 9:00am EST to review the Company’s quarterly financial statements for Q1 Fiscal Year 2022 (July 1 – September 30, 2021), and provide a corporate update.

Webinar Login Information:

	Date:	Tuesday, November 30, 2021
	Time:	6:00am PST / 9:00am EST
	URL:	www.reliqhealth.com/webinar

“In the webinar on November 30^th, Management will discuss the Q1 FY2022 financials, provide an update on Reliq’s operations to date and review guidance for calendar year 2022,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “The Company is on track to achieve a revenue run rate of $2 Million/month by the end of calendar year 2021 with gross margins of 75% and EBITDA margins of 45%. We expect to see significant growth quarter-over-quarter every quarter through calendar year 2022 and beyond as Medicare and Medicaid continue to expand the scope of their virtual care programs and the corresponding reimbursement amounts.”

For those who are not able to attend the webinar, a recording will be available on the Company’s website (www.reliqhealth.com) immediately following the session.

Reliq Health

Reliq Health Technologies is a rapidly growing global medtech company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information please contact:

Company Contact
Investor Relations at ir@reliqhealth.com

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

FAQ

When is the Reliq Health Technologies Q1 FY2022 webinar?

The webinar is scheduled for November 30, 2021, at 6:00 AM PST / 9:00 AM EST.

What financial results will be discussed in the Reliq webinar?

The webinar will review the quarterly financial statements for Q1 Fiscal Year 2022, covering the period from July 1 to September 30, 2021.

What are the expected revenue and margins for Reliq Health Technologies?

Reliq expects to achieve a revenue run rate of $2 million/month by the end of 2021, with gross margins of 75% and EBITDA margins of 45%.

How does Reliq Health Technologies plan to grow in 2022?

Reliq anticipates significant growth quarter-over-quarter in 2022 as Medicare and Medicaid increase virtual care program reimbursements.